Gilead Sciences (GILD) Dividends Paid - Common (2009 - 2026)
Gilead Sciences' (GILD) quarterly Dividends Paid - Common came in at $1.0 billion in Q1 2026, up 3.09% YoY from $1.0 billion in Q1 2025, and up 4.23% on a QoQ basis from $993.0 million in Q4 2025.
Gilead Sciences (GILD) Dividends Paid - Common (2009 - 2026) Analysis & Trends
Gilead Sciences (GILD) has 13 years of Dividends Paid - Common data on file, last reported at $1.0 billion in Q1 2026.
- Quarterly Dividends Paid - Common rose 3.09% year-over-year to $1.0 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.0 billion (up 2.24% YoY) and the FY2025 annual result came in at $4.0 billion, up 1.81% from the prior year.
- Dividends Paid - Common improved to $1.0 billion in Q1 2026, from $993.0 million in the prior quarter.
- In the past five years, Dividends Paid - Common ranged from a high of $1.0 billion in Q1 2026 to a low of $928.0 million in Q4 2022.
- A 5-year average of $968.5 million and a median of $973.0 million in 2024 frame the typical range for Dividends Paid - Common.
- Annual changes were most pronounced in 2022 — Dividends Paid - Common advanced 4.15% — and 2023, when it gained 1.62%.
- Tracing GILD's Dividends Paid - Common over 5 years: stood at $928.0 million in 2022, then climbed by 1.62% to $943.0 million in 2023, then rose by 3.18% to $973.0 million in 2024, then climbed by 2.06% to $993.0 million in 2025, then grew by 4.23% to $1.0 billion in 2026.
- The last three Dividends Paid - Common figures came in at $1.0 billion (Q1 2026), $993.0 million (Q4 2025), and $995.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Div. Paid (Common) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 652.20 Bn | 631.44 Bn | 17.26 Bn | 3.23 Bn |
| 2 | AbbVie | 469.51 Bn | 462.94 Bn | 12.70 Bn | 3.07 Bn |
| 3 | Merck | 376.81 Bn | 369.67 Bn | 12.21 Bn | 2.14 Bn |
| 4 | Novartis Ag | 303.04 Bn | 295.35 Bn | 11.24 Bn | 2.87 Bn |
| 5 | Astrazeneca | 257.61 Bn | 252.71 Bn | 12.86 Bn | 6.58 Bn |
| 6 | Amgen | 237.37 Bn | 223.38 Bn | 7.24 Bn | 1.36 Bn |
| 7 | Gilead Sciences | 181.73 Bn | 178.55 Bn | 6.22 Bn | 1.03 Bn |
| 8 | Pfizer | 159.66 Bn | 147.96 Bn | 10.94 Bn | 2.45 Bn |
| 9 | Gsk | 106.24 Bn | 102.07 Bn | 8.24 Bn | - |
| 10 | Sanofi | 55.07 Bn | 47.69 Bn | 10.79 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.03 Bn |
| Jun 30, 2026 | 1.03 Bn |
| Mar 31, 2026 | 1.04 Bn |
| Mar 31, 2026 | 1.04 Bn |
| Dec 31, 2025 | 993.00 Mn |
| Dec 31, 2025 | 993.00 Mn |
| Sep 30, 2025 | 995.00 Mn |
| Sep 30, 2025 | 995.00 Mn |
| Jun 30, 2025 | 997.00 Mn |
| Jun 30, 2025 | 997.00 Mn |
| Mar 31, 2025 | 1.00 Bn |
| Mar 31, 2025 | 1.00 Bn |
| Dec 31, 2024 | 973.00 Mn |
| Dec 31, 2024 | 973.00 Mn |
| Sep 30, 2024 | 977.00 Mn |
| Sep 30, 2024 | 977.00 Mn |
| Jun 30, 2024 | 978.00 Mn |
| Jun 30, 2024 | 978.00 Mn |
| Mar 31, 2024 | 980.00 Mn |
| Mar 31, 2024 | 980.00 Mn |